science

Recombinant Immunotoxin Collaborative Group

Recombinant Immunotoxin Collaborative Group is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Recombinant Immunotoxin Collaborative Group rather than just read about it. In short: The Recombinant Immunotoxin Collaborative Group (RICG) is a group of scientists specialising in immunology, biochemistry and molecular biology from the United Kingdom and Italy. The group is working toward the development of genetically engineered immunotoxins made from monoclonal antibody fragments genetically fused to either saporin or Pseudomonas exotoxin (PE) for the treatment of human hematological malignancies…

Key takeaways

Recombinant Immunotoxin Collaborative Group belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Recombinant Immunotoxin Collaborative Group to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Recombinant Immunotoxin Collaborative Group from memory before moving on to harder problems.

Reference excerpt

The Recombinant Immunotoxin Collaborative Group (RICG) is a group of scientists specialising in immunology, biochemistry and molecular biology from the United Kingdom and Italy. The group is working toward the development of genetically engineered immunotoxins made from monoclonal antibody fragments genetically fused to either saporin or Pseudomonas exotoxin (PE) for the treatment of human hematological malignancies such as leukaemia, lymphoma and multiple myeloma.

Formation The RICG was formed in 2005 and originally consisted of Dr Aldo Ceriotti and Dr M. Serena Fabbrini (IBBA, CNR, Milan), Professor Marco Colombatti (University of Verona), Professor Rodolfo Ippoliti (University of L'Aquila), Dr Alessandro Pini (University of Siena) and Drs David Flavell and Sopsamorn Flavell (University of Southampton Medical School and Leukaemia Busters). Dr Alessandro Pini left the group in 2007.

Achievements The RICG was successful in producing a range of recombinant immunotoxins based on the monoclonal antibodies 4KB128 and OKT10 targeting CD22 and CD38, respectively on normal and malignant lymphoid cells. This development work was undertaken with funding from the UK-based charity Leukaemia Busters under the direction of Dr David Flavell, the charity's Scientific Director

Disbanding The group disbanded in 2009 due to funding difficulties following the global economic crisis but despite this the former members continue to collaborate in areas of mutual interest. In this respect some of the group members and their respective institutes have recently entered into a collaboration agreement with the Italian pharmaceutical company Dompé based in L’Aquila, central Italy with the intention of developing one of the RICG produced recombinant immunotoxins for investigation in early phase clinical trials for patients with leukaemia and lymphoma.

References

Worked examples

Example 1 — a first encounter with Recombinant Immunotoxin Collaborative Group

Start with the simplest possible case. Write down what Recombinant Immunotoxin Collaborative Group claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Recombinant Immunotoxin Collaborative Group before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Recombinant Immunotoxin Collaborative Group ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Recombinant Immunotoxin Collaborative Group

In research: Recombinant Immunotoxin Collaborative Group appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Recombinant Immunotoxin Collaborative Group in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Recombinant Immunotoxin Collaborative Group is common in secondary-school and first-year university syllabi. It links to neighbouring topics Immunology organizations, so understanding it makes those chapters shorter.
In everyday life: Look for Recombinant Immunotoxin Collaborative Group outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Recombinant Immunotoxin Collaborative Group” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Recombinant Immunotoxin Collaborative Group in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Recombinant Immunotoxin Collaborative Group means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Recombinant Immunotoxin Collaborative Group out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Recombinant Immunotoxin Collaborative Group in simple terms?

Why does Recombinant Immunotoxin Collaborative Group matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Recombinant Immunotoxin Collaborative Group?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Recombinant Immunotoxin Collaborative Group.